Is Tarsus Pharmaceuticals TARS stock failing to hold levels Tarsus Pharmaceuticals posts wider than expected EPS loss The real story behind Presidio SQFTW earnings numbers SQFTW QX Earnings Presidio Reports No Disclosed Financial Data This Quarter PUBM PubMatic posts Q4 2025 profit against consensus loss estimates shares rise 46 percent today The competitive edge that makes Angel ANGX special Weakens 20260506